All News
STAT+: Bhattacharya demures on his view on Trump’s slashing of NIH indirect costs
President Trump's nominee to lead the NIH, Jay Bhattacharya, demurred on his view on Trump’s move to slashi NIH indirect cost payments to universities and other instituions.
Read MoreSTAT+: Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price
Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers chase market share.
Read MoreFirst Generics for Low-Dose Rivaroxaban Get FDA Approval
(MedPage Today) -- The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday. Rivaroxaban 2.
Read MoreWho Is Trump's New Doctor?
(MedPage Today) -- President Trump's new physician is Sean Barbabella, DO, a Navy emergency physician who served in Afghanistan and Iraq, and has "extensive combat trauma experience," according to re
Read MoreHow Springing Forward to Daylight Saving Time Could Affect Your Health
(MedPage Today) -- Most of America "springs forward" Sunday for daylight saving time and losing that hour of sleep can do more than leave you tired and cranky the next day.
Read MoreBiologic May Spark Catch-Up Growth in Kids With Eczema
(MedPage Today) -- SAN DIEGO -- Biologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial analysis showed.
Read MoreTrump’s Nominee for N.I.H. Chief Faces Questions From Senators
Jay Bhattacharya, a health economist, gained prominence during the Covid pandemic when he argued against lockdowns.
Read MoreHow the race for the next obesity drug is shaping up
And other biotech news stories you need to read, brought to you by The Readout.
Read MoreThe mixed conservative response to Trump’s health moves
And more health news stories you need to read.
Read MoreSTAT+: Pharmalittle: We’re reading about lower Wegovy prices, a dispute over Merck’s Keytruda, and more
Novo Nordisk plans to offer its Wegovy weight loss drug at a reduced cost of $499 per month for cash-paying customers in the U.S.
Read More